Routine Preoperative Hemostatic Laboratory Evaluation Prior to Tonsillectomy or Adenoidectomy in Children
NCT ID: NCT00972361
Last Updated: 2011-08-26
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
COMPLETED
200 participants
OBSERVATIONAL
2009-01-31
2011-04-30
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
A proportion of those children reveal borderline abnormal values of Partial Prothrombin Time (aPTT) or Prothrombin Time (PT) and then they are referred to a consultant hematologist for further evaluation and recommendations before surgery.
The purpose of this study is to summarize the causes of referrals in a cohort of 200 children and to assess the further laboratory analysis preformed and the results obtained.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Tranexamic Acid and Pediatric Adenotonsillectomy
NCT01228136
Tonsillectomy and Risk of Post-Tonsillectomy Hemorrhage
NCT05161754
Tonsillectomy Versus Tonsillotomy in the Treatment of Recurrent Acute Tonsillitis
NCT06606262
Hemostasis Using Surgicel in Pediatric Tonsillectomy
NCT03984851
Injectable Platelet Rich Fibrin Post Tonsillectomy
NCT06304935
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
The data will include cause of referral, laboratory analysis performed and results.
If the data allows the outcome of the operation and bleeding complications, will also recorded.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
CASE_ONLY
RETROSPECTIVE
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
Exclusion Criteria
12 Months
18 Years
ALL
No
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
HaEmek Medical Center, Israel
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Dr Koren Ariel
Head of Pediatric Hematology Unit and Pediatric Dpt B
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
Ariel Koren, MD
Role: PRINCIPAL_INVESTIGATOR
Pediatric Dpt B and Pediatric Hemaology Unit - Ha'Emek Medical Center - Afula - Israel
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
Pediatric Hematology Unit and Pediatric Dpt B - HaEmek Medical Center
Afula, , Israel
Countries
Review the countries where the study has at least one active or historical site.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
0134-08-EMC
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.